Captopril pretreatment augments diabetogenic response to streptozotocin administration: experimental in vivo rat model
Abstract Background Streptozotocin (STZ) is a glucose analogue commonly used for inducing diabetes in experimental animals. This study is intended to investigate the ability of captopril (Cap) pretreatment to augment STZ-induced diabetogenic effect in an experimental rat model. If this hypothesis we...
Saved in:
Main Authors: | Hayam Ateyya (Author), Asmaa Mohammed ShamsEldeen (Author), Sara Adel Hosny (Author), Samaa Samir Kamar (Author), Laila Ahmed Rashed (Author), Abeer Mostafa (Author), Inas Harb (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic regulation of diabetogenic adipose morphology
by: A.G. Kerr, et al.
Published: (2019) -
Diabetogenically beneficial gut microbiota alterations in third trimester of pregnancy
by: Emmanuel Amabebe, et al.
Published: (2021) -
Captopril Pretreatment Produces an Additive Cardioprotection to Isoflurane Preconditioning in Attenuating Myocardial Ischemia Reperfusion Injury in Rabbits and in Humans
by: Yi Tian, et al.
Published: (2015) -
Assessment of IV albumin and ringer lactate on the acute oral toxicity of acetylsalicylic acid in albino rats
by: Inas Harb, et al.
Published: (2024) -
Evaluation of the diabetogenic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: a pilot study
by: Tannaz Dehpouri, et al.
Published: (2019)